Genmab A-S
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $5,861,743 | $4,932,685 | $6,441,000 | $5,540,000 |
Gross Profit | 5,500,533 | 4,642,933 | 6,104,000 | 5,267,000 |
EBITDA | 2,838,984 | 265,000 | 2,355,000 | 2,204,000 |
EBIT | 2,737,592 | 249,000 | 2,267,000 | 2,119,000 |
Net Income | 2,129,238 | 195,000 | 3,845,000 | 1,266,000 |
Net Change In Cash | 5,861,743 | 4,932,685 | 6,441,000 | 5,540,000 |
Free Cash Flow | 329,525 | 1,746,155 | 2,618,000 | 1,985,000 |
Cash | 8,212,777 | 8,212,777 | 9,858,000 | 6,342,000 |
Basic Shares | 619,926 | 639,340 | 641,540 | 648,850 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $21,526,000 | $16,474,000 | $14,595,000 | $8,482,000 |
Gross Profit | 20,541,000 | 16,248,000 | 14,595,000 | 8,482,000 |
EBITDA | 9,697,000 | 5,561,000 | 7,346,000 | 3,147,000 |
EBIT | 9,284,000 | 5,321,000 | 6,984,000 | 2,897,000 |
Net Income | 7,844,000 | 4,352,000 | 5,452,000 | 2,957,000 |
Net Change In Cash | 21,526,000 | 16,474,000 | 14,595,000 | 8,482,000 |
Free Cash Flow | 7,584,000 | 7,004,000 | 3,595,000 | 1,976,000 |
Cash | 9,858,000 | 14,867,000 | 9,893,000 | 8,957,000 |
Basic Shares | 646,330 | 659,150 | 660,100 | 660,460 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.54 |
2025-03-31 | $0.31 |
2024-12-31 | $0.84 |
